185 related articles for article (PubMed ID: 21634377)
1. Identification of a potent, state-dependent inhibitor of Nav1.7 with oral efficacy in the formalin model of persistent pain.
Bregman H; Berry L; Buchanan JL; Chen A; Du B; Feric E; Hierl M; Huang L; Immke D; Janosky B; Johnson D; Li X; Ligutti J; Liu D; Malmberg A; Matson D; McDermott J; Miu P; Nguyen HN; Patel VF; Waldon D; Wilenkin B; Zheng XM; Zou A; McDonough SI; DiMauro EF
J Med Chem; 2011 Jul; 54(13):4427-45. PubMed ID: 21634377
[TBL] [Abstract][Full Text] [Related]
2. Discovery and biological evaluation of 5-aryl-2-furfuramides, potent and selective blockers of the Nav1.8 sodium channel with efficacy in models of neuropathic and inflammatory pain.
Kort ME; Drizin I; Gregg RJ; Scanio MJ; Shi L; Gross MF; Atkinson RN; Johnson MS; Pacofsky GJ; Thomas JB; Carroll WA; Krambis MJ; Liu D; Shieh CC; Zhang X; Hernandez G; Mikusa JP; Zhong C; Joshi S; Honore P; Roeloffs R; Marsh KC; Murray BP; Liu J; Werness S; Faltynek CR; Krafte DS; Jarvis MF; Chapman ML; Marron BE
J Med Chem; 2008 Feb; 51(3):407-16. PubMed ID: 18176998
[TBL] [Abstract][Full Text] [Related]
3. 3-Oxoisoindoline-1-carboxamides: potent, state-dependent blockers of voltage-gated sodium channel Na(V)1.7 with efficacy in rat pain models.
Macsari I; Besidski Y; Csjernyik G; Nilsson LI; Sandberg L; Yngve U; Ahlin K; Bueters T; Eriksson AB; Lund PE; Venyike E; Oerther S; Hygge Blakeman K; Luo L; Arvidsson PI
J Med Chem; 2012 Aug; 55(15):6866-80. PubMed ID: 22770500
[TBL] [Abstract][Full Text] [Related]
4. A disubstituted succinamide is a potent sodium channel blocker with efficacy in a rat pain model.
Priest BT; Garcia ML; Middleton RE; Brochu RM; Clark S; Dai G; Dick IE; Felix JP; Liu CJ; Reiseter BS; Schmalhofer WA; Shao PP; Tang YS; Chou MZ; Kohler MG; Smith MM; Warren VA; Williams BS; Cohen CJ; Martin WJ; Meinke PT; Parsons WH; Wafford KA; Kaczorowski GJ
Biochemistry; 2004 Aug; 43(30):9866-76. PubMed ID: 15274641
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Inactive States of Tetrodotoxin-Sensitive Sodium Channels Reduces Spontaneous Firing of C-Fiber Nociceptors and Produces Analgesia in Formalin and Complete Freund's Adjuvant Models of Pain.
Matson DJ; Hamamoto DT; Bregman H; Cooke M; DiMauro EF; Huang L; Johnson D; Li X; McDermott J; Morgan C; Wilenkin B; Malmberg AB; McDonough SI; Simone DA
PLoS One; 2015; 10(9):e0138140. PubMed ID: 26379236
[TBL] [Abstract][Full Text] [Related]
6. Direct evidence for high affinity blockade of Na
Gonçalves TC; Boukaiba R; Molgó J; Amar M; Partiseti M; Servent D; Benoit E
Neuropharmacology; 2018 May; 133():404-414. PubMed ID: 29474819
[TBL] [Abstract][Full Text] [Related]
7. A-803467, a potent and selective Nav1.8 sodium channel blocker, attenuates neuropathic and inflammatory pain in the rat.
Jarvis MF; Honore P; Shieh CC; Chapman M; Joshi S; Zhang XF; Kort M; Carroll W; Marron B; Atkinson R; Thomas J; Liu D; Krambis M; Liu Y; McGaraughty S; Chu K; Roeloffs R; Zhong C; Mikusa JP; Hernandez G; Gauvin D; Wade C; Zhu C; Pai M; Scanio M; Shi L; Drizin I; Gregg R; Matulenko M; Hakeem A; Gross M; Johnson M; Marsh K; Wagoner PK; Sullivan JP; Faltynek CR; Krafte DS
Proc Natl Acad Sci U S A; 2007 May; 104(20):8520-5. PubMed ID: 17483457
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological characterization of potent and selective NaV1.7 inhibitors engineered from Chilobrachys jingzhao tarantula venom peptide JzTx-V.
Moyer BD; Murray JK; Ligutti J; Andrews K; Favreau P; Jordan JB; Lee JH; Liu D; Long J; Sham K; Shi L; Stöcklin R; Wu B; Yin R; Yu V; Zou A; Biswas K; Miranda LP
PLoS One; 2018; 13(5):e0196791. PubMed ID: 29723257
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological characterization of synthetic analogs of Huwentoxin-IV (Mu-theraphotoxin-Hh2a), a neuronal tetrodotoxin-sensitive sodium channel inhibitor.
Deng M; Luo X; Jiang L; Chen H; Wang J; He H; Liang S
Toxicon; 2013 Sep; 71():57-65. PubMed ID: 23726857
[TBL] [Abstract][Full Text] [Related]
10. A-887826 is a structurally novel, potent and voltage-dependent Na(v)1.8 sodium channel blocker that attenuates neuropathic tactile allodynia in rats.
Zhang XF; Shieh CC; Chapman ML; Matulenko MA; Hakeem AH; Atkinson RN; Kort ME; Marron BE; Joshi S; Honore P; Faltynek CR; Krafte DS; Jarvis MF
Neuropharmacology; 2010 Sep; 59(3):201-7. PubMed ID: 20566409
[TBL] [Abstract][Full Text] [Related]
11. The effect of kappa-opioid receptor agonists on tetrodotoxin-resistant sodium channels in primary sensory neurons.
Su X; Castle NA; Antonio B; Roeloffs R; Thomas JB; Krafte DS; Chapman ML
Anesth Analg; 2009 Aug; 109(2):632-40. PubMed ID: 19608841
[TBL] [Abstract][Full Text] [Related]
12. Comparative evaluation of in vitro and in vivo high glucose-induced alterations in voltage-gated tetrodotoxin-resistant sodium channel: Effects attenuated by sodium channel blockers.
Kharatmal SB; Singh JN; Sharma SS
Neuroscience; 2015 Oct; 305():183-96. PubMed ID: 26255676
[TBL] [Abstract][Full Text] [Related]
13. Voltage-gated sodium channel function and expression in injured and uninjured rat dorsal root ganglia neurons.
Yin R; Liu D; Chhoa M; Li CM; Luo Y; Zhang M; Lehto SG; Immke DC; Moyer BD
Int J Neurosci; 2016; 126(2):182-92. PubMed ID: 25562420
[TBL] [Abstract][Full Text] [Related]
14. Distinct repriming and closed-state inactivation kinetics of Nav1.6 and Nav1.7 sodium channels in mouse spinal sensory neurons.
Herzog RI; Cummins TR; Ghassemi F; Dib-Hajj SD; Waxman SG
J Physiol; 2003 Sep; 551(Pt 3):741-50. PubMed ID: 12843211
[TBL] [Abstract][Full Text] [Related]
15. Phenoxyphenyl pyridines as novel state-dependent, high-potency sodium channel inhibitors.
Shao B; Victory S; Ilyin VI; Goehring RR; Sun Q; Hogenkamp D; Hodges DD; Islam K; Sha D; Zhang C; Nguyen P; Robledo S; Sakellaropoulos G; Carter RB
J Med Chem; 2004 Aug; 47(17):4277-85. PubMed ID: 15293999
[TBL] [Abstract][Full Text] [Related]
16. Heterologous expression and functional analysis of rat Nav1.8 (SNS) voltage-gated sodium channels in the dorsal root ganglion neuroblastoma cell line ND7-23.
John VH; Main MJ; Powell AJ; Gladwell ZM; Hick C; Sidhu HS; Clare JJ; Tate S; Trezise DJ
Neuropharmacology; 2004 Mar; 46(3):425-38. PubMed ID: 14975698
[TBL] [Abstract][Full Text] [Related]
17. Functional tetrodotoxin-resistant Na(+) channels are expressed presynaptically in rat dorsal root ganglia neurons.
Medvedeva YV; Kim MS; Schnizler K; Usachev YM
Neuroscience; 2009 Mar; 159(2):559-69. PubMed ID: 19162133
[TBL] [Abstract][Full Text] [Related]
18. Inactivation properties of sodium channel Nav1.8 maintain action potential amplitude in small DRG neurons in the context of depolarization.
Patrick Harty T; Waxman SG
Mol Pain; 2007 May; 3():12. PubMed ID: 17540018
[TBL] [Abstract][Full Text] [Related]
19. Effects of a new potent analog of tocainide on hNav1.7 sodium channels and in vivo neuropathic pain models.
Ghelardini C; Desaphy JF; Muraglia M; Corbo F; Matucci R; Dipalma A; Bertucci C; Pistolozzi M; Nesi M; Norcini M; Franchini C; Camerino DC
Neuroscience; 2010 Aug; 169(2):863-73. PubMed ID: 20580661
[TBL] [Abstract][Full Text] [Related]
20. Modulation of peripheral Na(+) channels and neuronal firing by n-butyl-p-aminobenzoate.
Thériault O; Poulin H; Sculptoreanu A; de Groat WC; O'Leary ME; Chahine M
Eur J Pharmacol; 2014 Mar; 727():158-66. PubMed ID: 24486399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
